Asahi Kasei (3407) Q3 2025 earnings summary

Executive summary

• Year-on-year operating income increased in all segments, with significant improvement in Material due to strong demand in semiconductors and electronics, and appropriate product pricing; Homes and Health Care also performed well.

• Operating income forecast revised upward, driven by Digital Solutions, Veloxis in Pharmaceuticals, and a weaker yen.

• Business portfolio transformation continues, focusing on growth businesses and structural transformation of petrochemical chain-related businesses.

• Full-year dividend forecast maintained at ¥36 per share; share repurchase of up to ¥30 billion in progress.

• Net sales for Q1–Q3 2024 rose 9.5% year-over-year to ¥2,259,252 million, with operating income up 66.9% to ¥164,389 million and net income attributable to owners up 68.1% to ¥98,475 million.

Financial highlights

• Net sales for Apr.–Dec. 2024 rose by ¥195.1 billion (+9.5%) to ¥2,259.3 billion year-over-year.

• Operating income increased by ¥65.9 billion (+66.9%) to ¥164.4 billion; net income attributable to owners of the parent up by ¥39.9 billion (+68.1%) to ¥98.5 billion.

• EBITDA for Apr.–Dec. 2024 was ¥299.8 billion (+28.4% year-over-year); operating margin improved to 7.3%.

• Gross profit for Q1–Q3 2024 was ¥716,582 million, up from ¥602,223 million year-over-year.

• Ordinary income rose 69.4% to ¥153,286 million; net income per share increased to ¥71.11 from ¥42.25.

Outlook and guidance

• FY2024 net sales forecast revised downward to ¥3,044.0 billion (+9.3% year-over-year), but operating income forecast revised upward to ¥200.0 billion (+42.1%).

• Net income attributable to owners of the parent forecast unchanged at ¥110.0 billion (+151.1% year-over-year).

• All segments expected to see year-on-year operating income growth, with Digital Solutions, Critical Care, and other growth businesses contributing.

• Dividend per share forecast at ¥36; payout ratio targeted at 30–40% over three years.

• Annual dividend forecast maintained at ¥36.00 per share.